157 related articles for article (PubMed ID: 36895786)
1. Construction of a TTN Mutation-Based Prognostic Model for Evaluating Immune Microenvironment, Cancer Stemness, and Outcomes of Colorectal Cancer Patients.
Zhao L; Fan W; Luo K; Xie S; Wang R; Guan J; Chen Z; Jin S
Stem Cells Int; 2023; 2023():6079957. PubMed ID: 36895786
[TBL] [Abstract][Full Text] [Related]
2. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.
Liu J; Yu F; Liu Z; Wang X; Li J
Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265
[No Abstract] [Full Text] [Related]
3. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
Chen Q; Tang P; Huang H; Qiu X
Front Immunol; 2022; 13():934124. PubMed ID: 35958575
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer.
Ma XB; Xu YY; Zhu MX; Wang L
Front Oncol; 2020; 10():591739. PubMed ID: 33680920
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
6. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
7. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
8. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
9. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
10. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
11. A Prognostic Model Using Immune-Related Genes for Colorectal Cancer.
Feng W; Zhang Y; Liu W; Wang X; Lei T; Yuan Y; Chen Z; Song W
Front Cell Dev Biol; 2022; 10():813043. PubMed ID: 35252182
[TBL] [Abstract][Full Text] [Related]
12. Novel acetylation-related gene signatures for predicting the prognosis of patients with colorectal cancer.
Jing Z; Ziwang F; Yinhang W; Yani Z; Jian C; Jingwen W; Shuwen H
Hum Cell; 2022 Jul; 35(4):1159-1173. PubMed ID: 35604486
[TBL] [Abstract][Full Text] [Related]
13. Role of ferroptosis-related genes in prognostic prediction and tumor immune microenvironment in colorectal carcinoma.
Yang C; Huang S; Cao F; Zheng Y
PeerJ; 2021; 9():e11745. PubMed ID: 34316400
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
[TBL] [Abstract][Full Text] [Related]
15. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients.
Wang S; Cheng L; Jing F; Li G
BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638
[TBL] [Abstract][Full Text] [Related]
16. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
Front Oncol; 2021; 11():626961. PubMed ID: 33747944
[TBL] [Abstract][Full Text] [Related]
17. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
[TBL] [Abstract][Full Text] [Related]
18. Construction and Validation of an Immune-Related Prognostic Model Based on TP53 Status in Colorectal Cancer.
Zhao X; Liu J; Liu S; Yang F; Chen E
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31689990
[TBL] [Abstract][Full Text] [Related]
19. Classification of colorectal carcinoma subtypes based on ferroptosis-associated molecular markers.
Yue Q; Zhang Y; Wang F; Cao F; Duan X; Bai J
World J Surg Oncol; 2022 Apr; 20(1):117. PubMed ID: 35410338
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.
Li X; Xie M; Yin S; Xiong Z; Mao C; Zhang F; Chen H; Jin L; Lan P; Lian L
Front Genet; 2021; 12():666003. PubMed ID: 34017356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]